Industry News 21 Oct 2026

FDA recalls GLP-1 drug, other injectable medication over sterility concerns

Source: Fox 4 News Dallas-fort Worth •By chris williams •1 min read

Apothecary Pharma is recalling 23 vials of compounded injectable drugs distributed nationwide because their sterility cannot be assured, according to the Food and Drug Administration.

This is a short summary. The full story is published by Fox 4 News Dallas-fort Worth.

Read full story at Fox 4 News Dallas-fort Worth
#pharma#recall#recalls

Related news

Industry News
FDA Classifies Apothecary Pharma's Tirzepatide Recall as Class II

The U.S. recall began Sept. 24 and includes 22 tirzepatide lots and one lot of Apothecary NAD+ Injection.

Econotimes• 21 Oct 2026 •1 min read
#apothecary pharma#compounding pharmacy#drug recall
Read story
Industry News
Sun Pharma to present long-term cancer drug data at ESMO 2026

UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell…

Indianpharmapost• 23 Oct 2026 •1 min read
#cancer drug#diseases#pharma
Read story
Industry News
Torrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27

Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr…

The Free Press Journal• 23 Oct 2026 •1 min read
#financial markets#fpj shorts#pharma
Read story
Industry News
Roche Pharma Sales Beat Q3 Consensus Forecast by CHF 350 Million

Group sales rose 8% in Swiss francs to CHF 16.13 billion, and Roche kept its 2026 growth outlook.

Econotimes• 23 Oct 2026 •1 min read
#financial markets#pharma#pharmaceuticals
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit